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1028 The Journal of Thoracic and CardObjective: The purpose of this study was to investigate (1) the early and midterm
patency rates in saphenous vein grafts that were anastomosed with the Symmetry
Aortic Connector System (St Jude Medical, Inc, St Paul, Minn) and (2) risk factors
for graft occlusion.
Methods: Thirty-one patients underwent off-pump coronary artery bypass grafting
for proximal saphenous vein graft anastomoses with the aortic connector system.
Intraoperative graft flow was studied with transit time flowmetry, and angiography
was performed before discharge in 29 cases. Midterm (at least 1 year after the
operation) saphenous vein graft patency was assessed by coronary angiography or
3-dimensional coronary computed tomography in 27 cases.
Results: Postoperative angiography demonstrated a 100% patency rate and no
significant stenosis at the connector-anastomosed sites. The 1-year patency rate of
the saphenous vein grafts with the aortic connector system was 92.6%, with 2 cases
of saphenous vein graft occlusion. Both of these cases had low graft flow and poor
left ventricular function documented during the operation.
Conclusion: Once surgical errors had been ruled out, the 1-year patency rate of
proximal saphenous vein grafts anastomosed with the aortic connector system was
favorable. Poor left ventricular function and low graft flow during the operation
were risk factors for midterm graft occlusion. Selection of the target vessel and its
runoff may also be an important determinant of long-term patency.
T he Symmetry Aortic Connector System (ACS; St Jude Medical, Inc, St Paul,Minn) is a device that can be used to eliminate aortic manipulation duringanastomoses of vein grafts.1-3 Previous reports have demonstrated that the
combination use of off-pump coronary artery bypass grafting (OPCAB) and the
ACS resulted in a lower rate of postoperative cerebrovascular events.4-6 However,
the patency rates of grafts placed with the assistance of the ACS remain controver-
sial,7-11 with some reports showing a high incidence of graft occlusion when using
the ACS for anastomoses.12-16 The goal of this study was to investigate the early and
midterm patency rates of ACS grafts and to characterize risk factors associated with
midterm graft occlusion.
Material and Methods
From May 2002 to June 2003, a total of 387 patients underwent isolated OPCAB by the same
surgeon at our institution. Total arterial revascularization, including the gastroepiploic artery,
was used for treatment of multivessel disease.17,18 When the gastroepiploic artery was not
available or was ill-suited for use as a graft,19 revascularization was achieved with saphenous
vein grafts (SVGs). In patients with calcification or atheroma of the ascending aorta, aortic
clamping was deferred in favor of proximal anastomoses with the ACS. Of a total of 387
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CDcases, 31 patients underwent proximal SVG anastomoses with the
ACS and were evaluated for this study. Emergency cases were
defined as any cases in which diagnosis and subsequent surgery
took place on the same day.
OPCAB Procedures
The saphenous vein was harvested by trained surgeons with the
open technique. Heparin (1 mg/kg) was used to maintain activated
clotting time at greater than 250 seconds and was halfway reversed
with protamine in nearly all cases after anastomosis. Veins were
mounted on the correctly sized device by the primary surgeon
according to diameter. Proximal anastomoses were performed first,
followed by distal anastomoses. Anastomoses were performed
with 7-0 polypropylene continuous suture and assisted by Octopus
mechanical stabilization (Medtronic Inc, Minneapolis, Minn).
Graft Evaluation
Intraoperative graft flow was evaluated with a flowmeter (Car-
dioMeds; Medi-Stim, Oslo, Norway) according to the transit time
principle. Angiographic evaluation of graft patency was performed
before hospital discharge in 29 cases.
Anticoagulation and Antiplatelet Treatments
Heparin (200 U/kg) was administered routinely on postoperative
days 1 through 4. Postoperative medical therapy included aspirin
(100 mg/d orally) in all cases. Other antiplatelet drugs or warfarin
sodium were given to 8 patients because of coexisting arterial
disease or atrial fibrillation.
Postoperative Follow-up and Graft Evaluation
Postoperative information was obtained by direct contact with the
patients or through telephone conversations with patients or their
families. Three-dimensional computed tomography (SOMATOM
TABLE 1. Clinical profile of 31 patients
Age (y)
Mean  SD 69.7 9.9
Range 48-86
Female (No.) 9 (29.0%)
Ejection fraction (%)
Mean  SD 60.9%  12.8%
Range 33%-78%
Left main trunk stenosis (No.) 14 (45.2%)
Three-vessel disease (No.) 20 (64.5%)
Two-vessel disease (No.) 11 (35.5%)
Emergency operation (No.) 5 (16.1%)
Preoperative intra-aortic balloon pump (No.) 3 (9.7%)
Previous coronary artery bypass grafting (No.) 3 (9.7%)
Previous percutaneous coronary intervention
(No.)
19 (61.3%)
Old myocardial infarction (No.) 13 (41.9%)
Hypertension (No.) 24 (77.4%)
Diabetes mellitus (No.) 12 (38.7%)
Hyperlipidemia (No.) 18 (58.1%)
Chronic renal failure (No.) 4 (12.9%)Sensation 16; Siemens AG, Munich, Germany) was performed at
The Journal of Thoracicleast 1 year after the operation in 26 cases, and those results were
evaluated by a reliable radiologist. Coronary angiography was
performed in 1 case.
Statistical Analysis
Data were gathered from clinical records and analyzed with Stat-
View version 5.0 (SAS Institute, Inc, Cary, NC). Numeric data
were analyzed with the Mann-Whitney and t tests. Categorical data
were analyzed by 2 analysis. Results are expressed as mean 
SD.
Results
Preoperative variables are summarized in Table 1. Mean age
at operation was 69.7 years. Mean left ventricular ejection
fraction was 60.9%. Operative details are summarized in
Table 2. There were no operative or in-hospital deaths, and
none of the patients had cerebral infarctions or transient
ischemic attacks during hospitalization. Twenty-nine pa-
tients underwent postoperative coronary angiography before
discharge, with a 100% patency rate and without significant
stenosis for proximal anastomoses performed with the ACS.
The follow-up data gathering rate was 100%, with a
mean follow-up of 573 days (range 188-852 days). Three of
the patients died during the follow-up period (cancer n  2,
chronic renal failure n 1). The 1-year survival was 93.5%.
Follow-up graft evaluation was performed in 27 cases,
demonstrating 2 cases of SVG occlusion. The 1-year SVG
patency rate was 92.6%. Perioperative details of occluded
TABLE 2. Operative details for 31 patients
Internal thoracic artery grafts (No.)
Left 24
Right 17
Gastroepiploic artery graft (No.) 1
SVGs (No.) 31
Total distal anastomoses (No.) 108
Distal anastomoses per patient 3.48  1.15
ACS size (mm)
4.5-5.0 (No.) 24 (77.4%)
5.0-5.5 (No.) 5 (16.1%)
5.5-6.0 (No.) 2 (6.5%)
Intraoperative SVG flow (mL/min)
Mean  SD 47.3  19.8
Range 9.9-81
Target coronary arteries for SVG (No.)
Right 17
Right and circumflex 5
Circumflex 4
Left anterior descending 1
Left anterior descending and circumflex 1
Right and diagonal 1
Circumflex and diagonal 1
Diagonal 1
ACS, Aortic Connector System; SVG, saphenous vein graft.grafts and patent grafts are summarized in Table 3. Analysis
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graft flow during operation and poor left ventricular func-
tion were significant risk factors for graft occlusion (P 
.0206 and P  .0415, respectively).
Discussion
Several reports have demonstrated that concomitant use of
the ACS and OPCAB in patients undergoing surgical re-
vascularization results in a lower rate of postoperative ce-
rebrovascular events,1-6 which is consistent with observa-
tions from this study that no patients had cerebral
infarctions or transient ischemic attacks during the postop-
erative period. We therefore believe these techniques to be
beneficial even in high-risk cases.
Concerning early graft patency, Donsky and colleagues12
reported thrombotic occlusions of ACS sites, and there have
been several reports of early occlusion with ACS associated
with graft kinking or inadequate graft angle.7,8 In this study,
results showed acceptable early graft patency. We selected
target vessels that seemed to possess enough runoff to
distinguish the cause of early occlusion as being from the
aortic device rather than from poor runoff. As well as
technical aspects, selection of target vessels and routine
heparin use might result in good early postoperative pa-
tency. The ACS is composed of nitinol, which may cause
intimal hyperplasia and lead to midterm stenosis and occlu-
sion.13-16 However, the incidences of these events seemed to
be higher than with a nitinol stent.20 Bergsland and associ-
ates13 reported that half of the Symmetry grafts were oc-
cluded and that an additional 25% had intraconnector ste-
TABLE 3. Details of occluded versus patent grafts
Variable
Occluded
(n  2)
Patent
(n  25) P value
Age (y, mean) 67 69.6 9.4 .579
Ejection fraction (%) 42% 62.9% 8.8% .0415
Left main trunk stenosis (No.) 0 11 .603
Emergency operation (No.) 1 4 .234
Preoperative intra-aortic
balloon pump (No.)
0 3 .603
Previous percutaneous
coronary intervention (No.)
2 14 .223
Old myocardial infarction
(No.)
2 10 .100
Graft flow (mL/min, mean) 14.5 48.9 18.9 .0206
Hypertension (No.) 1 15 .782
Diabetes mellitus (No.) 0 11 .223
Hyperlipidemia (No.) 1 15 .782
Chronic renal failure (No.) 1 2 .069
Other than aspirin (No.) 0 6 .432
ACS size (mean) 5 4.63 0.30 .956
SDs are given for means for patent group. ACS, Aortic Connector System.nosis at a mean of 4.8 postoperative months. By contrast,
1030 The Journal of Thoracic and Cardiovascular Surgery ● OctHirayama and colleagues reported that nitinol stent resteno-
sis was observed in only 17% of cases at 6 months of
follow-up.20 In this study, early graft patency rate was
satisfactory, and midterm occlusion rates did not exceed
those reported in the literature for hand-sewn polypropylene
sutures.9,21-23 We speculated that once technical errors, such
as graft kinking or inadequate graft angle, were ruled out in
the postoperative course, acceptable midterm graft patency
could be expected.
However, statistical analysis demonstrated that poor in-
traoperative graft flow and poor left ventricular function
were significantly associated with midterm graft occlusion.
These conditions also meant poor runoff. Selection of target
vessels and their runoff thus may also be important to
long-term patency.
Conclusion
Once intraoperative technical errors were eliminated, the
midterm patency rate of ACS was acceptable; however,
poor runoff contributed to midterm graft occlusion. Selec-
tion of target vessels is important for long term patency.
We thank Dr Kenji Makisumi of the Department of
Radiology at Kokura Memorial Hospital for performing and
interpreting the 3-dimensional computed tomographic stud-
ies used in this study.
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